UnitedHealth Group Incorporated (NYSE:UNH) is Payden & Rygel’s 3rd Largest Position

Payden & Rygel lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 15.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,830 shares of the healthcare conglomerate’s stock after selling 11,100 shares during the period. UnitedHealth Group accounts for about 2.1% of Payden & Rygel’s investment portfolio, making the stock its 3rd biggest holding. Payden & Rygel’s holdings in UnitedHealth Group were worth $29,718,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. 25 LLC acquired a new stake in UnitedHealth Group in the first quarter valued at approximately $28,000. Cascade Investment Advisors Inc. acquired a new position in UnitedHealth Group during the 1st quarter valued at about $28,000. Kalos Management Inc. acquired a new stake in UnitedHealth Group in the first quarter worth about $34,000. Strategic Investment Solutions Inc. IL acquired a new position in shares of UnitedHealth Group during the first quarter valued at about $35,000. Finally, Clear Investment Research LLC boosted its stake in UnitedHealth Group by 216.7% in the 1st quarter. Clear Investment Research LLC now owns 76 shares of the healthcare conglomerate’s stock worth $36,000 after purchasing an additional 52 shares in the last quarter. 85.69% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UNH traded down $3.53 during trading hours on Friday, hitting $536.29. 2,676,925 shares of the stock were exchanged, compared to its average volume of 2,390,124. UnitedHealth Group Incorporated has a 12-month low of $445.68 and a 12-month high of $553.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.80 and a current ratio of 0.80. The stock’s 50-day moving average price is $519.50 and its two-hundred day moving average price is $498.44. The company has a market cap of $496.03 billion, a price-to-earnings ratio of 23.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.63.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, October 13th. The healthcare conglomerate reported $6.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.33 by $0.23. UnitedHealth Group had a return on equity of 26.58% and a net margin of 6.02%. The business had revenue of $92.36 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the business earned $5.79 earnings per share. The business’s revenue was up 14.2% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 24.94 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, December 4th will be issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Friday, December 1st. UnitedHealth Group’s dividend payout ratio is presently 32.64%.

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 4,498 shares of UnitedHealth Group stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $544.28, for a total value of $2,448,171.44. Following the completion of the sale, the executive vice president now owns 9,218 shares in the company, valued at approximately $5,017,173.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Stephen J. Hemsley sold 121,515 shares of the firm’s stock in a transaction that occurred on Tuesday, October 17th. The shares were sold at an average price of $540.58, for a total value of $65,688,578.70. Following the completion of the transaction, the director now owns 521,818 shares of the company’s stock, valued at $282,084,374.44. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 4,498 shares of the stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $544.28, for a total transaction of $2,448,171.44. Following the sale, the executive vice president now owns 9,218 shares in the company, valued at $5,017,173.04. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts have issued reports on UNH shares. HSBC initiated coverage on shares of UnitedHealth Group in a report on Wednesday, September 6th. They issued a “hold” rating and a $540.00 price target for the company. Morgan Stanley cut their price target on shares of UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a report on Monday, October 23rd. Jefferies Financial Group upped their price objective on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company a “hold” rating in a report on Monday, October 9th. StockNews.com cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 21st. Finally, Royal Bank of Canada lifted their price objective on UnitedHealth Group from $572.00 to $596.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $578.30.

Read Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.